EX-10.2 4 d296933dex102.htm EX-10.2 SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis Securities Exchange Agreement (this “Agreement”) is dated as of November 28, 2016, between Stemcells, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • May 11th, 2017 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 11th, 2017 Company Industry JurisdictionThis Securities Exchange Agreement (this “Agreement”) is dated as of May 10, 2017, between Microbot Medical Inc. (f/k/a Stemcells, Inc.), a Delaware corporation (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).
SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • December 23rd, 2016 • Catasys, Inc. • Services-misc health & allied services, nec • New York
Contract Type FiledDecember 23rd, 2016 Company Industry JurisdictionThis Securities Exchange Agreement (this “Agreement”) is dated as of _________, between Catasys, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • December 16th, 2016 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 16th, 2016 Company Industry JurisdictionThis Securities Exchange Agreement (this “Agreement”) is dated as of December 16, 2016, between Microbot Medical Inc. (f/k/a Stemcells, Inc.), a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • November 29th, 2016 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 29th, 2016 Company Industry JurisdictionThis Securities Exchange Agreement (this “Agreement”) is dated as of November 28, 2016, between Stemcells, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • July 1st, 2009 • Juhl Wind, Inc • Services-management services • New York
Contract Type FiledJuly 1st, 2009 Company Industry JurisdictionThis Securities Exchange Agreement (this “Agreement”) is dated as of June 30, 2009, between Juhl Wind, Inc., a Delaware corporation (the “Company”), and each security holder identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).